Department of Ophthalmology Grand Rounds

When:
September 19, 2024 @ 8:30 am – 10:00 am
2024-09-19T08:30:00-07:00
2024-09-19T10:00:00-07:00
Where:
HYBRID: VCV013E - William and Ruth Hoffman Auditorium, 1st Floor
490 Illinois Street
San Francisco
CA 94158
Contact:
Meelan Bravo

8:30 am – 9:15 am — Case Presentations: VA (Bryan Winn)

9:15 am – 10:00 am — Grand Rounds: “Repairing genetic disease with allele-specific CRISPR editing”, Bruce Conklin, MD

  1. Understand how CRISPR works.
  2. Understand the potential of therapeutic editing.
  3. Understand the opportunities for therapeutics in the visual system.

Disclosures:  Presenter Dr. Bruce Conklin, MD has the following financial relationships to disclose: Scientist.com (Assay Depot), Arbor Therapeutics & Spotlight Therapeutics – Consultant and Tenaya Therapeutics – Founder- with Stock.

Planner Yvonne Ou, MD, has received research funding from Astellas Institute for Regenerative Medicine and advises for Oculinea and Janssen.

Target Audience: Physicians and Advanced Practice Providers.

Accreditation: In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation: UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This presentation receives support from UCSF’s (non-commercial) Samuel J. Kimura Fund, Transamerica Lecture Fund and Proctor Lecture Fund.